Dermatology · Boston, MA
NPI
1437562659
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
221 Longwood Ave
Boston, MA, 02115
Phone (617) 582-4918
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,087 services
Medicare patients, 2024
325
Average age 71
Drug cost, 2024
$4.9M
1,489 prescriptions
Company payments, 2025
$12K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Avery H Lachance was code 99214 (office e&m - established), 540 times for 264 patients. In total Avery H Lachance billed 1,087 services in 37 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 540 | 264 | $79.00 | $43K |
| 17003 Destruction Skin Lesion | Office | 170 | 42 | $1.69 | $287 |
| 17000 Destruction Skin Lesion | Office | 77 | 59 | $46.97 | $3,617 |
| 11102 Skin Biopsy | Office | 44 | 40 | $22.99 | $1,012 |
| 99213 Office E&M - Established | Office | 40 | 36 | $49.38 | $1,975 |
| 99204 Office E&M - New | Office | 32 | 32 | $102.20 | $3,270 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 24 | $13.77 | $427 |
| 11104 Skin Biopsy | Office | 26 | 26 | $38.12 | $991 |
| 99215 Office E&M - Established | Office | 20 | 17 | $110.98 | $2,220 |
| 11105 Skin Biopsy | Office | 15 | 11 | $21.19 | $318 |
| 17110 Destruction Skin Lesion | Office | 12 | 11 | $60.86 | $730 |
By year: 2022 $32K for 573 services; 2023 $40K for 720 services; 2024 $63K for 1,087 services.
Medicare prescription drug claims, 2024
In 2024, the drug Avery H Lachance prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 80 prescriptions and refills. In total Avery H Lachance wrote 1,489 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 80 | 119 | 15 | $1,823 |
| Methotrexate Methotrexate Sodium | 67 | 109 | 18 | $2,095 |
| Clobetasol Propionate Generic | 66 | 72 | 33 | $4,267 |
| Ketoconazole Generic | 60 | 85 | 27 | $898 |
| Tacrolimus Generic | 59 | 66 | 25 | $7,008 |
| Dupixent Pen Dupilumab | 58 | 58 | Under 11 | $251K |
| Dupixent Syringe Dupilumab | 58 | 58 | Under 11 | $241K |
| Minoxidil Generic | 51 | 110 | 13 | $387 |
| Triamcinolone Acetonide Generic | 49 | 75 | 32 | $775 |
| Taltz Autoinjector Ixekizumab | 49 | 49 | Under 11 | $324K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 41 | 50 | 23 | $2,735 |
| Betamethasone Dipropionate Generic | 36 | 38 | 22 | $2,665 |
| Tretinoin Generic | 34 | 44 | 13 | $2,643 |
| Otezla Apremilast | 34 | 34 | Under 11 | $163K |
| Valacyclovir Valacyclovir Hcl | 33 | 33 | Under 11 | $335 |
Brand drugs: 606 claims; generic drugs: 870 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Avery H Lachance $12K ($12K in general payments such as food, travel and fees) from 6 companies. The largest payer was Janssen Biotech, Inc. with $8,416.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.